GENE ONLINE|News &
Opinion
Blog

Regulatory
Trials & Approvals Breast Cancer
Yet Another Feather in Merck’s Crown, Keytruda Meets Endpoint in Phase 3 Trial for Triple Negative Breast Cancer
2020-02-13
Trials & Approvals AI
First AI-Guided Ultrasound ECHO Software Approved for Marketing
2020-02-12
Trials & Approvals Pain Management
Trevena Inc. Gives Oliceridine Approval Another Shot
2020-02-11
Trials & Approvals Multiple Sclerosis
Sanofi’s BTK Inhibitor Meets Primary Endpoint in Phase 2 Trial Amidst Criticism
2020-02-07
Trials & Approvals AI
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
Trials & Approvals H5N1
Seqirus’ AUDENZTM, a Vaccine against Potential Flu Epidemic Gets FDA Approval
2020-02-05
R&D
Insmed Soaring High with Positive Phase II Results for Non Cystic Fibrosis Bronchiectasis Drug, INS1007
2020-02-03
Trials & Approvals Gene Therapy
FDA Issues Guidances Supporting Development of Gene Therapy Products
2020-02-02
Trials & Approvals Peanut Allergy
Aimmune’s PALFORZIA™ Scores FDA Win, Becomes the First Ever Treatment For Peanut Allergy
2020-02-01
Trials & Approvals Acid Sphingomyelinase
First Sanofi Designed Investigational Enzyme Replacement Therapy for ASMD Gets Green Signal in Phase II/III Trial
2020-01-31
Trials & Approvals Thyroid Eye Disease
FDA Greenlights Tepezza as First Treatment for Thyroid Eye Disease
2020-01-22
Trials & Approvals NK Cell
Weekly Cover: Acepodia’s NK Cell Therapy Drug Candidate ACE1702 Receives FDA Clearance of IND
2020-01-15
Trials & Approvals Pembrolizumab
Keytruda Flounders Lung Cancer Trial but Scores Key Win for Bladder Cancer
2020-01-14
Trials & Approvals Bladder Cancer
Bavencio Meets Primary Endpoint in Bladder Cancer Trial
2020-01-09
Trials & Approvals
Ubrelvy Approval, the Best New Year Gift for CGRP Migraine Victims
2020-01-09
1 … 48 49 50 51 52 53
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top